The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ESPERION THERAPEUTICS INC NE | COMMON | 29664W105 | 14,485 | 289,000 | SH | DFND | 1 | 0 | 0 | 289,000 | |
| ESPERION THERAPEUTICS INC NE | COMMON | 29664W105 | 5 | 100 | SH | DFND | 0 | 0 | 100 | ||
| MACROGENICS INC. | COMMON | 556099109 | 14,958 | 787,260 | SH | DFND | 1 | 0 | 0 | 787,260 | |
| MEDICINES CO | COMMON | 584688105 | 84,076 | 3,075,202 | SH | DFND | 2 | 0 | 0 | 3,075,202 | |
| MEDICINES CO | COMMON | 584688105 | 4 | 100 | SH | DFND | 0 | 0 | 100 | ||
| MIRATI THERAPEUTICS INC | COMMON | 60468T105 | 57,231 | 3,135,966 | SH | DFND | 1 | 0 | 0 | 3,135,966 | |